Cargando…

The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series

Proteasome inhibitor bortezomib has been used in the treatment of refractory cases of acute and chronic antibody-mediated rejection (AMR) in kidney transplant recipients. However, its efficacy and safety as a primary treatment for early AMR has been scarcely investigated. We herein present our preli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolonko, Aureliusz, Słabiak-Błaż, Natalia, Karkoszka, Henryk, Więcek, Andrzej, Piecha, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074248/ https://www.ncbi.nlm.nih.gov/pubmed/32075220 http://dx.doi.org/10.3390/jcm9020529

Ejemplares similares

Association between Kidney Donor Risk Index, kidney graft function and histological changes in early post-transplant graft biopsy
por: Słabiak-Błaż, Natalia, et al.
Publicado: (2023)

The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation
por: Kolonko, Aureliusz, et al.
Publicado: (2021)

Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
por: Kolonko, Aureliusz, et al.
Publicado: (2023)

Clinical Outcomes of Transplanted Kidneys from Deceased Donors Using Different Generic Preservation Solutions
por: Kolonko, Aureliusz, et al.
Publicado: (2022)

Arterial stiffness but not endothelial dysfunction is associated with multidrug antihypertensive therapy and nondipper blood pressure pattern in kidney transplant recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2018)

Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents
por: Kolonko, Aureliusz, et al.
Publicado: (2020)

Potential Utility of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Neutrophil, Lymphocyte, and Platelet Ratios in Differential Diagnosis of Kidney Transplant Acute Rejection: A Retrospective, Propensity Score Matched Analysis
por: Kolonko, Aureliusz, et al.
Publicado: (2022)

Endogenous Mammalian Cardiotonic Steroids—A New Cardiovascular Risk Factor?—A Mini-Review
por: Słabiak-Błaż, Natalia, et al.
Publicado: (2021)

The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2018)

Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants
por: Musialik, Joanna, et al.
Publicado: (2022)

Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic
por: Kolonko, Aureliusz, et al.
Publicado: (2021)

Transplanted kidney loss during colorectal cancer chemotherapy: A case report
por: Pośpiech, Marta, et al.
Publicado: (2022)

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
por: Krzyżowska, Kinga, et al.
Publicado: (2018)

The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2014)

The effect of Maintenance Treatment with Twice-daily or Prolonged Once-daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2020)

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
por: Lee, Juhan, et al.
Publicado: (2015)

Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
por: Giza, Piotr, et al.
Publicado: (2020)

Influence of Chronic Periodontitis on the Long-Term Mortality and Cardiovascular Events in Kidney Transplant Recipients
por: Wynimko, Marta, et al.
Publicado: (2020)

Cardiovascular Risk Factors in Patients Before and After Successful Liver Transplantation
por: Gojowy, Damian, et al.
Publicado: (2022)

Bortezomib alleviates antibody‐mediated rejection in kidney transplantation by facilitating Atg5 expression
por: Cheng, Hong, et al.
Publicado: (2021)

Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
por: Chedid, Marcio F., et al.
Publicado: (2019)

Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1
por: Piecha, Grzegorz, et al.
Publicado: (2010)

Cardiotonic Steroids—A Possible Link Between High-Salt Diet and Organ Damage
por: Paczula, Aneta, et al.
Publicado: (2019)

Clinical factors increasing discrepancies of renal function assessment with MDRD and Cockcroft–Gault equations in old individuals
por: Chudek, Jerzy, et al.
Publicado: (2018)

The lipid story in chronic kidney disease: a long story with a happy end?
por: Kujawa-Szewieczek, Agata, et al.
Publicado: (2012)

Visual evoked potentials as a method for the prospective assessment of tacrolimus neurotoxicity in patients after kidney transplantation
por: Sirek, Sebastian, et al.
Publicado: (2022)

Relationship between plasma levels of sclerostin, calcium–phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients
por: Pietrzyk, Barbara, et al.
Publicado: (2018)

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
por: Iesari, Samuele, et al.
Publicado: (2017)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

The Effects of Short-Term Changes in Sodium Intake on Plasma Marinobufagenin Levels in Patients with Primary Salt-Sensitive and Salt-Insensitive Hypertension
por: Łabno-Kirszniok, Katarzyna, et al.
Publicado: (2021)

Type 1 Diabetic Patients After Simultaneous Pancreas and Kidney Transplantation Have Less Intense Periodontal Inflammation Compared to Kidney Recipients Treated with Insulin
por: Musiał, Mikołaj, et al.
Publicado: (2021)

Coincidence of cellular and antibody mediated rejection in heart transplant recipients – preliminary report
por: Zakliczyński, Michał, et al.
Publicado: (2014)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report
por: Kaźmierczak, Olga, et al.
Publicado: (2021)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Recent advances in renal transplantation: antibody-mediated rejection takes center stage
por: Pouliquen, Eric, et al.
Publicado: (2015)

Lung Ultrasound B-lines Occurrence in Relation to Left Ventricular Function and Hydration Status in Hemodialysis Patients
por: Pardała, Agnieszka, et al.
Publicado: (2019)

Bortezomib in Kidney Transplantation
por: Raghavan, Rajeev, et al.
Publicado: (2010)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b8q3kq9gia2chblhmvj85aaqon